SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-004112
Filing Date
2020-03-02
Accepted
2020-03-02 14:48:10
Documents
6
Period of Report
2020-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200228_8k.htm 8-K 39278
2 EXHIBIT 4.1 ex_174753.htm EX-4.1 109561
3 EXHIBIT 4.2 ex_174754.htm EX-4.2 115862
4 EXHIBIT 5.1 ex_174756.htm EX-5.1 9315
5 EXHIBIT 10.1 ex_174755.htm EX-10.1 182113
6 EXHIBIT 99.1 ex_174757.htm EX-99.1 10577
  Complete submission text file 0001437749-20-004112.txt   468141
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20676224
SIC: 2836 Biological Products, (No Diagnostic Substances)